Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2009Arthritis Research & TherapyOpen Access

Recent developments in anti-rheumatic drugs in pediatrics: treatment of juvenile idiopathic arthritis

View Full Paper
Ask AI
Bookmark
Share

Authors

KHKristen HaywardSeattle Children's HospitalCWCarol A. WallaceCincinnati Children's Hospital Medical Center

Discussion

Loading...

Member takes

Implication

Key Points

Key points are not available for this paper at this time.

Cite This Study

Hayward et al. (2009) studied this question.

synapsesocial.com/papers/6a7064f326a7f98052dce4cchttps://doi.org/10.1186/ar2619
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Thalidomide and lenalidomide: Mechanism-based potential drug combinations2008 · 115 citations
  2. 2Physiological Mechanisms of Regulating Alloimmunity: Cytokines, CTLA-4, CD25+ Cells, and the Alloreactive T Cell Clone Size2002 · 76 citations
  3. 3Anakinra in the treatment of polyarticular-course juvenile rheumatoid arthritis: safety and preliminary efficacy results of a randomized multicenter study2008 · 141 citations
  4. 4Measuring clinical response and remission in juvenile idiopathic arthritis2007 · 46 citations
  5. 5Medical Treatment of Juvenile Idiopathic Arthritis2005 · 308 citations